CN1400899A - 2－甲基－噻唑烷－2,4－二甲酸和/或其生理上可耐受的盐作为抗癌剂的应用 - Google Patents

2－甲基－噻唑烷－2,4－二甲酸和/或其生理上可耐受的盐作为抗癌剂的应用 Download PDF

Info

Publication number
CN1400899A
CN1400899A CN01805095A CN01805095A CN1400899A CN 1400899 A CN1400899 A CN 1400899A CN 01805095 A CN01805095 A CN 01805095A CN 01805095 A CN01805095 A CN 01805095A CN 1400899 A CN1400899 A CN 1400899A
Authority
CN
China
Prior art keywords
thiazolidine
methyl
cancer
dicarboxylic acid
mtdc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01805095A
Other languages
English (en)
Chinese (zh)
Inventor
鲁迪·苏西洛
汉斯·罗美尔斯巴奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1400899A publication Critical patent/CN1400899A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN01805095A 2000-02-15 2001-02-15 2－甲基－噻唑烷－2,4－二甲酸和/或其生理上可耐受的盐作为抗癌剂的应用 Pending CN1400899A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
DE10008159.2 2000-02-15

Publications (1)

Publication Number Publication Date
CN1400899A true CN1400899A (zh) 2003-03-05

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01805095A Pending CN1400899A (zh) 2000-02-15 2001-02-15 2－甲基－噻唑烷－2,4－二甲酸和/或其生理上可耐受的盐作为抗癌剂的应用

Country Status (15)

Country Link
US (2) US6943185B2 (enExample)
EP (1) EP1255538B1 (enExample)
JP (1) JP2003522782A (enExample)
CN (1) CN1400899A (enExample)
AT (1) ATE252383T1 (enExample)
AU (1) AU783933B2 (enExample)
CA (1) CA2399709C (enExample)
DE (2) DE10008159B4 (enExample)
EA (1) EA004592B1 (enExample)
ES (1) ES2208571T3 (enExample)
MX (1) MXPA02007903A (enExample)
PL (1) PL357179A1 (enExample)
PT (1) PT1255538E (enExample)
TR (1) TR200302134T4 (enExample)
WO (1) WO2001060343A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
CN101838218A (zh) * 2002-02-28 2010-09-22 日本烟草产业株式会社 酯化合物及其医药用途
WO2005021486A1 (ja) * 2003-08-29 2005-03-10 Japan Tobacco Inc. エステル誘導体及びその医薬用途
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
AU2005297923B2 (en) * 2004-10-25 2010-12-23 Japan Tobacco Inc. Solid medicinal preparation improved in solubility and stability and process for producing the same
JP5439849B2 (ja) * 2008-02-28 2014-03-12 味の素株式会社 システイン誘導体
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Also Published As

Publication number Publication date
ATE252383T1 (de) 2003-11-15
EP1255538A2 (de) 2002-11-13
AU783933B2 (en) 2005-12-22
PT1255538E (pt) 2004-03-31
EA004592B1 (ru) 2004-06-24
DE50100833D1 (de) 2003-11-27
DE10008159A1 (de) 2001-09-06
MXPA02007903A (es) 2004-09-10
EA200200853A1 (ru) 2003-02-27
DE10008159B4 (de) 2005-08-18
US20050187271A1 (en) 2005-08-25
EP1255538B1 (de) 2003-10-22
PL357179A1 (en) 2004-07-26
WO2001060343A3 (de) 2002-05-30
TR200302134T4 (tr) 2004-01-21
ES2208571T3 (es) 2004-06-16
WO2001060343A2 (de) 2001-08-23
AU3919001A (en) 2001-08-27
US6943185B2 (en) 2005-09-13
US20030149085A1 (en) 2003-08-07
JP2003522782A (ja) 2003-07-29
CA2399709A1 (en) 2001-08-23
CA2399709C (en) 2007-05-15

Similar Documents

Publication Publication Date Title
AU2016222315B2 (en) Compositions of selenoorganic compounds and methods of use thereof
US12109191B2 (en) Materials and methods for inhibiting tumor growth
CN1400899A (zh) 2－甲基－噻唑烷－2,4－二甲酸和/或其生理上可耐受的盐作为抗癌剂的应用
ES2770113T3 (es) Análogos de la cisteamina resistentes a la ADO y sus usos
US20190060473A1 (en) Hsp90 inhibitor drug conjugates
AU2007204757B2 (en) Lanthionine-related compounds for the treatment of inflammatory diseases
US9102636B2 (en) Analgesic compounds, compositions, and uses thereof
US6451761B1 (en) N′N′-dichlorinated omega-amino acids and uses thereof
CA2664982C (en) Cleavable carnitine compound
CN114025766A (zh) 用于抑制gapdh的噁噻嗪化合物
CN101060840A (zh) 核糖－半胱氨酸通过提高细胞内谷胱甘肽的送递和atp的水平以治疗缺氧的用途
US9029419B2 (en) Use of zinc N-acetyltaurinate
WO2007076323A2 (en) Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
US20090298782A1 (en) Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof
JPWO1988000182A1 (ja) ｒ‐Ｌ‐グルタミル‐Ｌ‐システインエチルエステル及びそれを有効成分とする医薬

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20030305